<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01949129</url>
  </required_header>
  <id_info>
    <org_study_id>ALL SCTped FORUM 2012</org_study_id>
    <nct_id>NCT01949129</nct_id>
  </id_info>
  <brief_title>Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia</brief_title>
  <official_title>Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Anna Kinderkrebsforschung</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ALL SCTped Forum</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Anna Kinderkrebsforschung</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ALL SCTped 2012 FORUM is a multinational, multi-centre, randomized, controlled,
      prospective seamless phase II/III study for the therapy and therapy optimisation for children
      and adolescents with ALL in CR, who have an indication for HSCT (hematopoetic stem cell
      transplantation) with a myeloablative conditioning regimen.

      The stratification and randomisation of patients in first and following remission according
      to the individual transplantation modalities rests upon an indication for allogeneic HSCT AND
      on the availability of a suitable donor within the individual transplantation groups.

      Main objectives - Objective 1: Randomisation of TBI vs non-TBI conditioning regimen for
      patients with a HLA matched-sibling donor or unrelated HLA matched donor.

      We aim at showing that a non-total body irradiation (TBI) containing conditioning
      (Flu/Thio/ivBu or Flu/Thio/Treo) results in a non-inferior survival as compared to
      conditioning with TBI/Etoposide in children older than 4 years after HSCT from a Human
      leucocyte antigen (HLA) identical sibling donor (MSD) or a HLA matched donor (MD).

      - Objective 2: Stratification of patients with a HLA mismatched donor according to stem cell
      source.

      We aim at exploring event free survival (EFS) after HSCT from HLA mismatched donors using
      mismatched unrelated donors (MMD), mismatched cord blood or HLA haplo-identical family
      members with non TBI-conditioning regimen.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute and late side effects of TBI in combination with other chemotherapeutic are manifold to
      the growing organism and include severe organ dysfunction/failure due to toxicity. Although
      transplant associated mortality was reduced after HSCT in the last decade due to better HLA
      matching, infection prevention and control, the burden of late complications is still a
      matter of concern.Growth retardation, hormonal dysfunction, sterility and the risk of
      secondary cancer are the late consequences of TBI in children.However, so far no prospective
      study has demonstrated similar outcomes in paediatric ALL using chemo-conditioning regimen
      before HSCT.The reason for that are manifold: only a minority of children with ALL qualify
      for allogeneic HSCT as most patients are cured with modern chemotherapy approaches alone.
      Those with dismal prognosis are treated in HSCT centres that care for patients with different
      diseases. Therefore it is nearly impossible to answer complex outcome questions in single
      centres or even in single countries. International cooperation are essential to allow
      prospective randomized investigation within comparable patient cohorts. This study aims to
      explore the efficacy and efficiency of two different chemo-conditioning regimens (Flu/Thio
      with Treo or ivBu) in comparison to the standard conditioning regimen (TBI/VP16). All
      patients with an indication for HSCT, age &gt; 4 years and a matched donor (MD) or matched
      sibling donor (MSD) undergo randomisation between these two conditionings. The decision if
      the irradiation free conditioning is Flu/Thio/Treo or Flu/Thio/ivBu is stratified by country.
      Patients with age &lt; 4 years receive automatically the irradiation free conditioning. Patients
      with a mismatched donor are stratified according to the donor's stem cell source (cordblood,
      haploidentical tx or bone marrow/peripheral blood stem cells).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival (OS) Stratum 1 (randomisation TBI+ chemo-conditioning vs. chemo-conditioning only)</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Event free survival (EFS) Stratum 2 (mismatched donor transplantation)</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>EFS (Stratum 1)</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative Incidence of Treatment-related mortality (TRM) for Stratum 1 and 2</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative Incidence of Relapse for Stratum 1 and 2</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>acute and late toxicity for Stratum 1 and 2</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
    <description>according a preselection out of CTC3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OS (Stratum 2)</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Acute Graft versus Host Disease (aGVHD) according Glucksberg Scale and Seattle Criteria</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Secondary malignancies</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
    <description>Incidence, type and timepoint of occurence</description>
  </other_outcome>
  <other_outcome>
    <measure>Chronic Graft-versus-host disease (cGvHD) according Glucksberg Scale and Seattle Criteria</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Acute Lymphoblastic Leukaemia</condition>
  <arm_group>
    <arm_group_label>conditioning Flu/Thio/Treo or Flu/Thio/ivBu</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients &gt; 4 years with a MSD or MD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conditioning TBI/VP16</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>VP16: 60 mg/kg, 1 day TBI: 12 Gray in 6 fractions over 3 days patients &gt; 4 years with MSD and MD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>for mismatched donor (MMD) transplantation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients with mmd cordblood: Flu/Thio/Treo/ATG fres. or Alemtuzumab with haploidentical tx: Flu/Thio/Treo/ATG fres. or Alemtuzumab with mmd bm or pbsc:Flu/Thio/Treo or ivBU according country's decision</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>VP16</intervention_name>
    <description>60 mg/kg, administration: 1 day</description>
    <arm_group_label>conditioning TBI/VP16</arm_group_label>
    <other_name>Etoposide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>TBI</intervention_name>
    <description>12 Gy in 6 fractions over 3 days</description>
    <arm_group_label>conditioning TBI/VP16</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Thiotepa</intervention_name>
    <description>2x5 mg/kg, 1 day</description>
    <arm_group_label>conditioning Flu/Thio/Treo or Flu/Thio/ivBu</arm_group_label>
    <arm_group_label>for mismatched donor (MMD) transplantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Treosulfan</intervention_name>
    <description>14g/m² BS, 3 days</description>
    <arm_group_label>conditioning Flu/Thio/Treo or Flu/Thio/ivBu</arm_group_label>
    <arm_group_label>for mismatched donor (MMD) transplantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fludarabine</intervention_name>
    <description>30 mg/m² BS, 5 days</description>
    <arm_group_label>conditioning Flu/Thio/Treo or Flu/Thio/ivBu</arm_group_label>
    <arm_group_label>for mismatched donor (MMD) transplantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Busulfan</intervention_name>
    <description>iV, dosage according therapeutic drug monitoring, 4 days</description>
    <arm_group_label>conditioning Flu/Thio/Treo or Flu/Thio/ivBu</arm_group_label>
    <arm_group_label>for mismatched donor (MMD) transplantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with ALL (except for patients with B-ALL) who fulfil the following criteria:

          -  age at time of screening less than 18 years

          -  indication for allogeneic HSCT

          -  complete remission (CR) before HSCT

          -  written consent of the parents (legal guardian) and, if necessary, the minor patient
             via &quot;Informed Consent Form&quot;

          -  no pregnancy

          -  no secondary malignancy

          -  no previous HSCT

          -  HSCT is performed in a study participating centre

        Exclusion Criteria:

          -  Patients who do not fulfil the inclusion criteria

          -  Non Hodgkin-Lymphoma

          -  ALL with extramedullary involvement with indication for TBI

          -  CNS involvement at the timepoint of screening

          -  Trisomy 21

          -  The whole protocol or essential parts are declined either by patient himself/herself
             or the respective legal guardian

          -  No consent is given for saving and propagation of anonymous medical data for study
             reasons

          -  Severe concomitant disease that does not allow treatment according to the protocol at
             the investigator's discretion (e.g. malformation syndromes, cardiac malformations,
             metabolic disorders)

          -  Karnofsky / Lansky score &lt; 50%

          -  Subjects unwilling or unable to comply with the study procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christina Peters, Prof. MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>St. Anna Kinderspital, Vienna, Austria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Bader, Prof. MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Klinik für Kinder- u. Jugendheilkunde III, Johann Wolfgang Goethe Universität, Frankfurt, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Franco Locatelli, Prof. MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>DepaDepartment of Pediatric Hematology and Oncology IRCCS Ospedale, Rome, Italy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christina Peters, Prof. MD PhD</last_name>
    <phone>+43140170</phone>
    <phone_ext>3106</phone_ext>
    <email>christina.peters@stanna.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ingeborg Hirsch, MSc</last_name>
    <phone>+43140470</phone>
    <phone_ext>4755</phone_ext>
    <email>ingeborg.hirsch@ccri.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Sor Maria Ludovica, Department Hematology Stem Cell Transplant Unit</name>
      <address>
        <city>La Plata</city>
        <zip>1651</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergio M Gomez, MD</last_name>
      <email>sergiomgomez_46@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Sergio M Gomez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Children's Hospital Queensland Children's Cancer Centre</name>
      <address>
        <city>Herston</city>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Fraser, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Chris Fraser, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Cancer Centre The Royal Children's Hospital</name>
      <address>
        <city>Parkville, Melbourne</city>
        <zip>3052</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francoise Mechinaud, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Francoise Mechinaud, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Hospital for Children</name>
      <address>
        <city>Perth</city>
        <zip>6008</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Catherine Cole, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Catherine Cole, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sydney Children's Hospital</name>
      <address>
        <city>Randwick</city>
        <zip>2031</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracey O'Brien, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Tracey O'Brien, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Children`s Hospital at Westmead Oncology Unit</name>
      <address>
        <city>Sydney</city>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Shaw, Dr</last_name>
      <email>peter.shaw@health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Peter Shaw, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik für Kinder- und Jugendheilkunde, Abt. f. Hämato-Onkologie</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christinan Urban, Prof. MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>Christian Urban, Prof. MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik für Kinder- und Jugendheilkunde</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriele Kropshofer, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>Gabriele Kropshofer, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Anna Kinderspital</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Herbert Pichler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Universitaire des Enfants Reine Fabiola (HUDERF)</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alina Ferster, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Alina Ferster, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc (UCL) Hématologie et oncologie pédiatrique</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sophie Dupont, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Sophie Dupont, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Gent Pediatrische hemato-oncologie</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Viktoria Bourdon, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Viktoria Bourdon, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Leuven Kinderhemato-oncologie</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marleen Renard, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Marleen Renard, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alberta Children's Hospital Division of Pediatric Oncology</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T3B 6A8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tony Truong, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Tony Truong, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>BC Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3V4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kirk Schultz, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Kirk Schultz, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CancerCare Manitoba/University of Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 0V9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Donna Wall, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Donna Wall, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital for Sick Children University of Toronto Division of Haematology/Oncology</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maarten Egeler, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Maarten Egeler, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montreal Children's Hospital</name>
      <address>
        <city>Montral</city>
        <state>Quebec</state>
        <zip>H4A 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Mitchell, MD; PhD</last_name>
    </contact>
    <investigator>
      <last_name>David Mitchell, MD; PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Sainte-Justine Hematology-Oncology Division</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Henrique Bittencourt, MD; PhD</last_name>
    </contact>
    <investigator>
      <last_name>Henrique Bittencourt, MD; PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Pediatric Hematology and Oncology Teaching Hospital Motol, 2nd Medical School, Charles University</name>
      <address>
        <city>Prague</city>
        <zip>150 06</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petr Sedlacek, Prof</last_name>
      <email>petr.sedlacek@fnmotol.cz</email>
    </contact>
    <investigator>
      <last_name>Petr Sedlacek, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Paediatric Stem Cell Transplant and Immune Deficiency, Dept. for children and adolescents 4072, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianne Ifversen, MD</last_name>
      <email>ifversen@rh.regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Marianne Ifversen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Division of Hematology-Oncology and Stem Cell Transplantation, Hospital for Children and Adolescents, Univ. of Helsinki</name>
      <address>
        <city>Helsinki</city>
        <zip>00029 HUS</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Vettenranta, Prof. Dr.</last_name>
      <email>kim.vettenranta@hus.fi</email>
    </contact>
    <investigator>
      <last_name>Kim Vettenranta, Prof. MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Division of Hematology-Oncology, Children´s Hospital, Univ. of Turku</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Päivi Lahteenmaaki, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Päivi Lahteenmaaki, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte Jubert, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Charlotte Jubert, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justyna Kanold, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Justyna Kanold, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Lille, Service d'Hématologie Pédiatrique</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benedicte Bruno, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Benedicte Bruno, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IHOP / Lyon, Service Hématologie et d'Oncologie pédiatrique</name>
      <address>
        <city>Lyon</city>
        <zip>69372</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves Bertrand, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Yves Bertrand, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital la Timone Adulte</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerard Michel, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Gerard Michel, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Sirvent, Prof</last_name>
      <email>a-sirvent@chu-monpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Anne Sirvent, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nancy - Hopital d'Enfants</name>
      <address>
        <city>Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence Clement, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Laurence Clement, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nantes, Service d'onco hémato pédiatrie</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fanny Rialland, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Fanny Rialland, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Robert Debré</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JH Dalle, Prof.</last_name>
      <email>jhugues.dalle@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jean-Hugues Dalle, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes, Serive d'Onco-Pédiatrie</name>
      <address>
        <city>Rennes</city>
        <zip>35203</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginie Gandemer, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Virginie Gandemer, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rouen, Service d' Immuno-Hématologie Oncologie Pédiatrique</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Pierre Vannier, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Pierre Vannier, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg, Service d'hématologie et d'oncologie pédiatrique</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Paillard, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Catherine Paillard, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uniklinik RWTH Aachen, Kinder- und Jugendmedizin</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Udo Kontny, Prof. Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Olga Moser, Dr.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Udo Kontny, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörn-Sven Kühl, MD, PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Hedwig Deubzer, MD, PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Jörn-Sven Kühl, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn, Abteilung für Pädiatrische Hämatologie und Onkologie</name>
      <address>
        <city>Bonn</city>
        <zip>53113</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dagmar Dilloo, Prof. Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Stefan Schönberger, Dr.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Dagmar Dilloo, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Düsseldorf, Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immunologie</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roland Meisel, Prof. MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Friedhelm Schuster, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Roland Meisel, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen, Kinder- und Jugendklinik</name>
      <address>
        <city>Erlangen</city>
        <zip>1054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus Daniel Stachel, MD, PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Markus Metzler, MD, PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Markus Metzler, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen, Klinik für Kinderheilkunde III</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernhard Kremens, Prof. MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Oliver Basu, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Bernhard Kremens, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Johann Wolfgang Goethe-Universität, Klinik für Kinder- und Jugendmedizin (KKJM)</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Bader, Prof</last_name>
    </contact>
    <contact_backup>
      <last_name>Jan Soerensen, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Peter Bader, Prof. MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg, Zentrum für Kinder- und Jugendmedizin</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brigitte Strahm, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Charlotte Niemeyer, Prof. MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Brigitte Strahm, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Gießen, Zentrum für Kinder- und Jugendmedizin</name>
      <address>
        <city>Gießen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wilhelm Wössmann, Prof. MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Holger Hauch, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Wilhelm Wössmann, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Greifswald, Klinik und Poliklinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Lode, Prof. MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Silke Kietz, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Holger Lohde, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Halle (Saale), Universitätsklinik und Poliklinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Halle</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toralf Bernig, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Caspar Kühnöl, Dr.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Toralf Bernig, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Pädiatrische Hämatologie und Onkologie</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johanna Schrum, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Ingo Müller, MD, PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Johanna Schrum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover, Zentrum Kinderheilkunde und Jugendmedizin</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl-Walter Sykora, Prof. MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Martin Sauer, Prof. MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Karl-Walter Sykora, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg, Zentrum für Kinder- und Jugendmedizin</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johann Greil, MD, PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Joachim Kunz, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Johann Greil, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Jena, Sektion für Stammzelltransplantation</name>
      <address>
        <city>Jena</city>
        <zip>07745</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernd Gruhn, Prof. MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Karim Kentouche, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Bernd Gruhn, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UKSH - Universitätsklinikum Schleswig-Holstein, Klinik für Allgemeine Pädiatrie</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gunnar Cario, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Alexander Claviez, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Gunnar Cario, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Leipzig, Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Holger Christiansen, Prof. Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Lars Fischer, Dr.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Holger Christiansen, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München, Dr. von Haunersches Kinderspital</name>
      <address>
        <city>München</city>
        <zip>80337</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Albert, MD, PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Tobias Feuchtinger, Prof. MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Michael Albert, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik und Poliklinik für Kinder- und Jugendmedizin, gendmedizin Prüfer PD Dr. med. Kinderklinik München Schwabing</name>
      <address>
        <city>München</city>
        <zip>80804</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Irene Teichert- von Lüttichau, MD, PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Angela Wawer, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Irene Teichert- von Lüttichau, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster, Klinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Rössig, Prof. MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Birgit Burkhardt, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Claudia Rössig, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Regensburg, Klinik und Poliklinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Selim Corbacioglu, Prof. MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Jürgen Föll, MD, PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Selim Corbacioglu, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik für Kinder- und Jugendmedizin Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Lang, Prof. MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Manuel Teltschik, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Peter Lang, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm, Klinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Ulm</city>
        <zip>89075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ansgar Schulz, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Manfred Hönig, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Ansgar Schulz, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitäts-Kinderklinik Würzburg</name>
      <address>
        <city>Würzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul-Gerhardt Schlegel, Prof. MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Matthias Eyrich, Prof. MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Paul-Gerhardt Schlegel, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Sophia Children's Hospital BMT Unit</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stelios Graphakos, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Stelios Graphakos, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>United St. Istvan and St. Laszlo Hospital</name>
      <address>
        <city>Budapest</city>
        <zip>1097</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gergely Krivan, Prof. Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Krisztián Kallay, Dr. PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Gergely Krivan, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rambam Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Irina Zaidman, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Irina Zaidman, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Schneider Children`s Medical Center of Israel</name>
      <address>
        <city>Petach-Tikva</city>
        <zip>49202</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jerry Stein, Prof.MD</last_name>
      <email>jstein@clalit.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Michal Rada</last_name>
    </contact_backup>
    <investigator>
      <last_name>Jerry Stein, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dana Children's Hospital</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ronit Elhasid, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Ronit Elhasid, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria Policlinico S. Orsola-Malpighi di Bologna</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrea Pession, Prof. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Andrea Pession, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Mayer di Firenze SODc Tumori Pediatrici e TMO</name>
      <address>
        <city>Florence</city>
        <zip>50139</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tommaso Casini, MD</last_name>
    </contact>
    <investigator>
      <last_name>Tommaso Casini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Gaslini Genova Oncoematologia Pediatrica-</name>
      <address>
        <city>Genoa</city>
        <zip>16147</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Concetta Micalizzi, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Concetta Micalizzi, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O. San Gerardo di Monza Clinica Pediatrica</name>
      <address>
        <city>Monza</city>
        <zip>20900</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carmelo Rizzari, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Carmelo Rizzari, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Padova Oncoematologia Pediatrica</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giuseppe Basso, Prof. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Giuseppe Basso, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mario Zecca, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Mario Zecca, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Pisana U.O. di Oncoematologia Pediatrica A.O.</name>
      <address>
        <city>Pisa</city>
        <zip>56126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claudio Favre, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Claudio Favre, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Pediatrico Bambino Gesù</name>
      <address>
        <city>Rome</city>
        <zip>00165</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franco Locatelli, Prof. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Franco Locatelli, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Infantile Regina Margherita SC Oncoematologia e Centro Trapianti</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Franca Fagioli, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Franca Fagioli, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto per l'Infanzia Burlo Garofalo - IRCCS S.C.O. di Oncoematologia</name>
      <address>
        <city>Trieste</city>
        <zip>34137</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marco Rabusin, Prof. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Marco Rabusin, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Center Department of Pediatrics/BMT unit</name>
      <address>
        <city>Leiden</city>
        <zip>2300</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arjan Lankester, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Arjan Lankester, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital for Children (WKZ) Dept. of Haematology</name>
      <address>
        <city>Utrecht</city>
        <zip>3584</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Bierings, Dr</last_name>
      <email>m.bierings@umcutrecht.nl</email>
    </contact>
    <investigator>
      <last_name>Marc Bierings, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Starship Children's Hospital</name>
      <address>
        <city>Auckland</city>
        <zip>1142</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lochie Teague, MD</last_name>
      <email>lochiet@adhb.govt.nz</email>
    </contact>
    <investigator>
      <last_name>Lochie Teague, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital Rikshospitalet</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jochen Büchner, MD</last_name>
      <email>jocbuc@ous-hf.no</email>
    </contact>
    <investigator>
      <last_name>Jochen Büchner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital</name>
      <address>
        <city>Bratislava</city>
        <zip>83340</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabina Sufliarska, Prof.</last_name>
      <email>sabina.sufliarska@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Sabina Suffliarska, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Silvia Children's Hospital, Department of Pediatric Oncology (Avdelnig 321-322)</name>
      <address>
        <city>Göteborg</city>
        <zip>41685</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Mellgren, MD</last_name>
    </contact>
    <investigator>
      <last_name>Karin Mellgren, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Skane University Hospital, Dept. of Pediatrics, Section for Hematology and Oncology</name>
      <address>
        <city>Lund</city>
        <zip>22185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacek Toporski, MD</last_name>
      <email>jacek.toporski@skane.se</email>
    </contact>
    <investigator>
      <last_name>Jacek Toporski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital, Department of Pediatrics</name>
      <address>
        <city>Stockholm</city>
        <zip>14186</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacek Winiaarski, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jacek Winiarski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital, Dept. of Women's &amp; Children's Health Section for Pediatrics</name>
      <address>
        <city>Uppsala</city>
        <zip>75185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johan Arvidson, MD</last_name>
    </contact>
    <investigator>
      <last_name>Johan Arvidson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitäts-Kinderspital beider Basel (UKBB)</name>
      <address>
        <city>Basel</city>
        <zip>4056</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Von der Weid, Prof. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Nicolas Von der Weid, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HUG Hôpitaux Universitaire de Genève</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Ansari, Prof. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Marc Ansari, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitäts-Kinderspital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Güngör Tayfun, Prof. Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Jean-Pierre Bourquin, Prof. Dr.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Güngör Tayfun, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ankara University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mehmet Ertem, Prof. MD</last_name>
    </contact>
    <contact_backup>
      <last_name>, Prof. MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Mehmet Ertem</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GATA Pediatrik KİT Unitesi</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Orhan Gursel, MD; PhD</last_name>
    </contact>
    <investigator>
      <last_name>Orhan Gursel, MD; PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gazi University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulker Kocak, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Ulker Kocak, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Akdeniz University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Antalya</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alphan Kupesiz, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Alphan Kupesiz, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bahcesehir University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Antalya</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Akif Yesilipek, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Akif Yesilipek, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Acibadem University Atakent Hospital Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gulyuz Ozturk, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Gulyuz Ozturk, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bahcelievler Medicalpark Hospital Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tunc Fisgin, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Tunc Fisgin, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bahcesehir University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gulsun Karasu, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Gulsun Karasu, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medipol Mega Üniversite Hastanesi</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Volkan Hazar, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Volkan Hazar, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dokuzeylul University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Izmir</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hale Oren, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Hale Oren, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ege University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Izmir</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Savaş Kansoy, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Savaş Kansoy, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erciyes University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Kayseri</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Musa Karakukcu, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Musa Karakukcu, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medicalpark Samsun Hospital Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Samsun</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emel Ozyurek, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Emel Ozyurek, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ondokuzmayıs University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Samsun</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Davut Albayrak, Prof. MD</last_name>
    </contact>
    <investigator>
      <last_name>Davut Albayrak, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>Norway</country>
    <country>Slovakia</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>http://www.kinderkrebsforschung.at/</url>
    <description>St. Anna Kinderkrebsforschung</description>
  </link>
  <link>
    <url>http://www.stanna.at/content.php?p=1&amp;lang=de</url>
    <description>St. Anna Kinderspital</description>
  </link>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2013</study_first_submitted>
  <study_first_submitted_qc>September 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 24, 2013</study_first_posted>
  <last_update_submitted>February 15, 2016</last_update_submitted>
  <last_update_submitted_qc>February 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Anna Kinderspital, Austria</investigator_affiliation>
    <investigator_full_name>Prof. Christina Peters</investigator_full_name>
    <investigator_title>Univ.-Prof. Dr. Christina Peters</investigator_title>
  </responsible_party>
  <keyword>stem cell transplantation</keyword>
  <keyword>children and adolescents</keyword>
  <keyword>high risk acute lymphoblastic leukaemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
    <mesh_term>Leukemia, Lymphoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fludarabine</mesh_term>
    <mesh_term>Treosulfan</mesh_term>
    <mesh_term>Busulfan</mesh_term>
    <mesh_term>Etoposide</mesh_term>
    <mesh_term>Thiotepa</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

